Stoke Therapeutics, Inc.STOK stock score: 52/100

$26.93 · +0.90% · Scored Nov 19, 2026

Technical
53
Fundamental
52
News
51

The reading

Stoke Therapeutics (STOK) scores 52 out of 100, which reads neutral, higher than 54% of Healthcare stocks and 52% of the 4,118 US stocks we score.

The composite weights fundamentals 80% and technicals 20%: fundamentals read 52, technicals 53.

Among the fundamentals, Quick Ratio at 100 and Price Target at 100 score highest, while Earnings Profitability (Quarterly) at 0 weighs the most against it.

On the daily chart, trend-following indicators average 51 and contrarian oscillators 45.

News sentiment is neutral at 51; it is shown, not counted in the composite.

Since Aug 22, 2026 the composite has ranged from 41 to 55, and it is down 2 points over the period.

About Stoke Therapeutics

Stoke Therapeutics (STOK) is a biotechnology company that develops RNA medicines designed to increase the production of proteins that patients with certain genetic diseases make too little of. Its approach uses antisense oligonucleotides that act on how genes are processed, aiming to restore protein levels from the healthy copy of a gene. Its lead candidate, zorevunersen, is being tested in a Phase three trial for Dravet syndrome, a severe genetic epilepsy that begins in infancy and is usually caused by a mutation in the SCN1A gene. Under a partnership with Biogen, Stoke keeps rights to zorevunersen in the United States, Canada and Mexico, while Biogen holds rights in the rest of the world. Stoke has no approved products and funds its work with cash raised from investors and payments from Biogen. It is also developing candidates for other genetic diseases, including an eye disorder.

Stoke faces competition from seizure medicines used in Dravet syndrome, such as UCB’s Fintepla and Jazz Pharmaceuticals’ Epidiolex, and from other companies developing genetic therapies for the disease. Its edge rests on a drug that targets the cause of Dravet syndrome and on clinical data showing reductions in seizures along with improvements in cognition and behavior. Investors who follow STOK stock tend to watch results from the Phase three trial and the timing of a new drug application. Interactions with the FDA are closely followed. Milestone payments from Biogen, cash runway and progress in its other programs are other factors.

What’s driving the score

The strongest and weakest of the scorers that count toward STOK’s composite. Each returns 0–100, higher is more bullish — including metrics where low is good, like P/E.

Fundamental

52

Pulling it up

  • Quick ratio measures a company's ability to meet short-term obligations with liquid assets.

  • Price target score compares the current stock price to analyst consensus targets.

  • Current assets divided by current liabilities: the ability to pay short-term bills.

Holding it back

37 weighted scorers; 2 had no data today and are left out rather than counted as zero.

Technical · daily

48

Pulling it up

  • Where the close sits against its 50-day EMA.

  • Performance versus SPY compares the stock's returns to the S&P 500 index.

  • Candlestick patterns recognize specific price formations that historically suggest continuation or reversal.

Holding it back

  • Parabolic SAR (Stop and Reverse) provides trailing stop levels that follow price trends.

  • Where the close sits against its 200-day SMA.

  • SPY SMA 20 measures the S&P 500 (SPY) position relative to its 20-period moving average.

62 weighted scorers; 3 had no data today and are left out rather than counted as zero.

News · shown, not counted

Global News
51

Technical score by timeframe

ChartScoreWeight
Hourly591
Daily483
Weekly492
Monthly602

Composite score, last 90 days

05010052Aug 22, 2026Nov 19, 2026Aug 22, 2026: 54Aug 23, 2026: 54Aug 24, 2026: 54Aug 25, 2026: 55Aug 26, 2026: 55Aug 27, 2026: 54Aug 28, 2026: 52Aug 29, 2026: 52Aug 30, 2026: 52Aug 31, 2026: 50Sep 1, 2026: 51Sep 2, 2026: 51Sep 3, 2026: 48Sep 4, 2026: 48Sep 5, 2026: 48Sep 6, 2026: 48Sep 7, 2026: 48Sep 8, 2026: 49Sep 9, 2026: 48Sep 10, 2026: 47Sep 11, 2026: 47Sep 12, 2026: 47Sep 13, 2026: 47Sep 14, 2026: 48Sep 15, 2026: 45Sep 16, 2026: 44Sep 17, 2026: 47Sep 18, 2026: 46Sep 19, 2026: 46Sep 20, 2026: 46Sep 21, 2026: 46Sep 22, 2026: 48Sep 23, 2026: 46Sep 24, 2026: 45Sep 25, 2026: 43Sep 26, 2026: 43Sep 27, 2026: 43Sep 28, 2026: 44Sep 29, 2026: 45Sep 30, 2026: 45Oct 1, 2026: 45Oct 2, 2026: 44Oct 3, 2026: 44Oct 4, 2026: 44Oct 5, 2026: 43Oct 6, 2026: 43Oct 7, 2026: 42Oct 8, 2026: 42Oct 9, 2026: 43Oct 10, 2026: 43Oct 11, 2026: 43Oct 12, 2026: 43Oct 13, 2026: 41Oct 14, 2026: 41Oct 15, 2026: 43Oct 16, 2026: 43Oct 17, 2026: 43Oct 18, 2026: 42Oct 19, 2026: 44Oct 20, 2026: 46Oct 21, 2026: 46Oct 22, 2026: 46Oct 23, 2026: 44Oct 24, 2026: 44Oct 25, 2026: 44Oct 26, 2026: 45Oct 27, 2026: 46Oct 28, 2026: 46Oct 29, 2026: 47Oct 30, 2026: 47Nov 1, 2026: 48Nov 2, 2026: 48Nov 3, 2026: 50Nov 4, 2026: 50Nov 5, 2026: 46Nov 6, 2026: 48Nov 7, 2026: 48Nov 8, 2026: 48Nov 10, 2026: 49Nov 11, 2026: 49Nov 12, 2026: 50Nov 13, 2026: 51Nov 14, 2026: 51Nov 15, 2026: 51Nov 16, 2026: 51Nov 17, 2026: 51Nov 18, 2026: 51Nov 19, 2026: 52
Show the daily numbers
DateComposite
Nov 19, 202652
Nov 18, 202651
Nov 17, 202651
Nov 16, 202651
Nov 15, 202651
Nov 14, 202651
Nov 13, 202651
Nov 12, 202650
Nov 11, 202649
Nov 10, 202649
Nov 8, 202648
Nov 7, 202648
Nov 6, 202648
Nov 5, 202646
Nov 4, 202650
Nov 3, 202650
Nov 2, 202648
Nov 1, 202648
Oct 30, 202647
Oct 29, 202647
Oct 28, 202646
Oct 27, 202646
Oct 26, 202645
Oct 25, 202644
Oct 24, 202644
Oct 23, 202644
Oct 22, 202646
Oct 21, 202646
Oct 20, 202646
Oct 19, 202644
Oct 18, 202642
Oct 17, 202643
Oct 16, 202643
Oct 15, 202643
Oct 14, 202641
Oct 13, 202641
Oct 12, 202643
Oct 11, 202643
Oct 10, 202643
Oct 9, 202643
Oct 8, 202642
Oct 7, 202642
Oct 6, 202643
Oct 5, 202643
Oct 4, 202644
Oct 3, 202644
Oct 2, 202644
Oct 1, 202645
Sep 30, 202645
Sep 29, 202645
Sep 28, 202644
Sep 27, 202643
Sep 26, 202643
Sep 25, 202643
Sep 24, 202645
Sep 23, 202646
Sep 22, 202648
Sep 21, 202646
Sep 20, 202646
Sep 19, 202646
Sep 18, 202646
Sep 17, 202647
Sep 16, 202644
Sep 15, 202645
Sep 14, 202648
Sep 13, 202647
Sep 12, 202647
Sep 11, 202647
Sep 10, 202647
Sep 9, 202648
Sep 8, 202649
Sep 7, 202648
Sep 6, 202648
Sep 5, 202648
Sep 4, 202648
Sep 3, 202648
Sep 2, 202651
Sep 1, 202651
Aug 31, 202650
Aug 30, 202652
Aug 29, 202652
Aug 28, 202652
Aug 27, 202654
Aug 26, 202655
Aug 25, 202655
Aug 24, 202654
Aug 23, 202654
Aug 22, 202654

Key facts

Market cap
$1.8B
Sector
Healthcare
Industry
Biotechnology
Beta
1.38
Risk grade (1–10)
10
Next earnings
Oct 29, 2026

Questions

What is STOK's stock rating today?

STOK scores 52/100 (Neutral) as of Nov 19, 2026: technical 53, fundamental 52, and news sentiment 51, which is shown but not counted. Scores are recomputed every night.

What does Stoke Therapeutics do?

Stoke Therapeutics (STOK) is a biotechnology company that develops RNA medicines designed to increase the production of proteins that patients with certain genetic diseases make too little of. Its approach uses antisense oligonucleotides that act on how genes are processed, aiming to restore protein levels from the healthy copy of a gene.

Is STOK stock a buy?

The score is not a buy or sell recommendation. A 52 says the technical and fundamental signals we measure lean neutral today, relative to every other stock scored the same way. Use the breakdown above to see why, and treat it as a starting point for your own research.

How is the STOK score calculated?

99 weighted scorers feed it today: 37 fundamental, scored against Healthcare ranges, and 62 technical on the daily chart, with 4 timeframes blended into the technical total. Every scorer returns 0–100; missing data is left out, never counted as zero.

Scores are information, not investment advice. Computed from Yahoo Finance, Finnhub and Alpha Vantage data; technical indicators via TA-Lib. Past scores do not predict future returns.

Embed this score

A badge for a blog post, newsletter or README. It updates every night and links back here. More badges

STOK stock score

HTML

<a href="https://stocksscores.com/stocks/stok/"><img src="https://stocksscores.com/stocks/stok/badge.svg" alt="STOK stock score" height="20"></a>

Markdown

[![STOK stock score](https://stocksscores.com/stocks/stok/badge.svg)](https://stocksscores.com/stocks/stok/)